Post-approval studies (Phase 4)Study completedNCT00631150
What this trial is testing
A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
Who this might be right for
Epilepsy
UCB Pharma 35